Bio-Rad Laboratories (BIO) Cash from Operations Growth (1y) (2010 - 2026)
Bio-Rad Laboratories (BIO) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.00 Bn | 175.71 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 128.69 Bn | 125.81 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.39 Bn | 66.93 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 47.97 Bn | 44.30 Bn | 1.29 Bn | -84.38% |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.00 Bn | 1.98 Bn | 16.00% |
| 7 | Dexcom | 28.21 Bn | 27.09 Bn | 750.30 Mn | 185.96% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 122.43% |
| 10 | Bio-Rad Laboratories | 8.54 Bn | 6.98 Bn | 309.40 Mn | -16.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.78% |
| Dec 31, 2025 | 32.77% |
| Sep 30, 2025 | -26.10% |
| Jun 30, 2025 | 19.36% |
| Mar 31, 2025 | 86.10% |
| Dec 31, 2024 | 53.33% |
| Sep 30, 2024 | 67.46% |
| Jun 30, 2024 | -0.49% |
| Mar 31, 2024 | -28.86% |
| Dec 31, 2023 | 1.75% |
| Sep 30, 2023 | 788.95% |
| Jun 30, 2023 | 84.00% |
| Mar 31, 2023 | 94.32% |
| Dec 31, 2022 | -53.42% |
| Sep 30, 2022 | -95.23% |
| Jun 30, 2022 | -65.53% |
| Mar 31, 2022 | -55.55% |
| Dec 31, 2021 | -41.94% |
| Sep 30, 2021 | 69.76% |
| Jun 30, 2021 | 67.90% |